Atlas Trials

Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer

Clinical trial NCT06448169 · UNKNOWN

Trial details

NCT number
NCT06448169
Sponsor
Shandong University
Status
UNKNOWN
Study type
OBSERVATIONAL
Triple Negative Breast CancerNeoadjuvant ImmunotherapySensitivity
Start date
2024-05-30
Primary completion
2026-02-28
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.